Combining N-of-1 Trials to Assess Fibromyalgia Treatments

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Fibromyalgia
Interventions
DRUG

Amitriptyline

Amitriptyline 25 mg po

DRUG

Amitriptyline plus Fluoxitine

Amitriptyline 25 mg po plus Fluoxitine 20 mg po

Trial Locations (7)

02402

Office of Raphael Kieval, MD, Brockton

02720

Office of Ronald J. Rapoport, MD, Fall River

01702

Office of Eileen Winston, MD, Framingham

02176

Office of Nicola Mogavero, MD, Melrose

02192

Office of Jacqueline Feuer, MD, Needham

02162

Newton-Wellesley Hospital, Newton

01864

Office of Sharon A. Stotsky, MD, North Reading

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Tufts Medical Center

OTHER

NCT00000428 - Combining N-of-1 Trials to Assess Fibromyalgia Treatments | Biotech Hunter | Biotech Hunter